1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA KIAA1468 CTRPv2 pan-cancer AAC 0.18 8e-09
mRNA PRKCQ CTRPv2 pan-cancer AAC 0.19 8e-09
mRNA BCL11A CTRPv2 pan-cancer AAC 0.21 8e-09
mRNA GDAP1L1 CTRPv2 pan-cancer AAC 0.24 8e-09
mRNA MBD1 CTRPv2 pan-cancer AAC 0.2 9e-09
mRNA ATXN7L3B CTRPv2 pan-cancer AAC 0.19 9e-09
mRNA ZNF420 CTRPv2 pan-cancer AAC 0.19 9e-09
mRNA H3F3A CTRPv2 pan-cancer AAC 0.19 9e-09
mRNA BCL7A CTRPv2 pan-cancer AAC 0.2 1e-08
mRNA WHSC1L1 CTRPv2 pan-cancer AAC 0.18 1e-08
Download CSV